Marshall Wace LLP Takes Position in Century Therapeutics, Inc. (NASDAQ:IPSC)
Marshall Wace LLP bought a new stake in Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 35,511 shares of the company’s stock, valued at approximately $36,000. Several other large investors have also recently bought and sold shares of IPSC. Barclays PLC boosted its position in […]
